Left atrial appendage closure device with delivery system: a health technology assessment
Health Quality Ontario
Record ID 32017000343
English
Authors' recommendations:
Moderate-quality evidence suggests that the LAAC device is as effective as novel oral anticoagulants in preventing stroke in people with nonvalvular atrial fibrillation. However, our results indicate that the LAAC device is cost-effective only in patients with contraindications to oral anticoagulants. People with nonvalvular atrial fibrillation with whom we spoke reported positive support for the LAAC device.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/evidence/reports/hta-left-atrial-appendage-closure-device-1706-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Anticoagulants
- Atrial Appendage
- Atrial Fibrillation
- Humans
- Technology Assessment, Biomedical
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.